Recent publications
Article
Dallan, B, Parry, H, Moss, P & Nicoli, F 2024, 'Age differentially impacts adaptive immune responses induced by adenoviral versus mRNA vaccines against COVID-19', Nature Aging, vol. 4, pp. 1121-1136. https://doi.org/10.1038/s43587-024-00644-w
Parry, H 2024, 'Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared to mRNA vaccines in haematopoietic cell transplant recipients', British Journal of Haematology. https://doi.org/10.1111/19874
OCTAVE-DUO investigators & Parry, H 2024, 'Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial', The Lancet Rheumatology, vol. 6, no. 6, pp. E339-E351. https://doi.org/10.1016/S2665-9913(24)00065-1
Loke, J, Upasani, V, Gaskell, C, Fox, S, Fletcher, R, Thomas, C, Hopkins, L, Kumari, A, Tang, T, Yafai, E, Boucher, R, Homer, V, Toth, A, Chan, YLT, Randall, K, Rider, T, O'nions, J, Drew, V, Pillai, A, Dungarwalla, M, Murray, D, Khan, A, Wandroo, F, Moore, S, Krishnamurthy, P, Huang, YJ, Knapper, S, Byrne, J, Zhao, R, Craddock, C, Parry, H, Moss, P, Stanworth, SJ & Lowe, DM 2023, 'Defective T‐cell response to COVID‐19 vaccination in acute myeloid leukaemia and myelodysplastic syndromes', British Journal of Haematology, vol. 202, no. 3, pp. 498-503. https://doi.org/10.1111/bjh.18894
Barber, VS, Peckham, N, Duley, L, Francis, A, Abhishek, A, Moss, P, Cook, JA & Parry, HM 2023, 'Protocol for a multicentre randomised controlled trial examining the effects of temporarily pausing Bruton tyrosine kinase inhibitor therapy to coincide with SARS-CoV-2 vaccination and its impact on immune responses in patients with chronic lymphocytic leukaemia', BMJ open, vol. 13, no. 9, e077946. https://doi.org/10.1136/bmjopen-2023-077946
Parry, H, Moss, P, Stephens, C, Bentley, C, Brown, K, Amirthalingam, G, Hallis, B, Otter, A, Zuo, J & Moss, P 2022, 'Extended interval BNT162b2 vaccination enhances peak antibody generation', NPJ vaccines, vol. 7, no. 1, 14. https://doi.org/10.1038/s41541-022-00432-w
Walewska, R, Parry-Jones, N, Eyre, TA, Follows, G, Martinez-Calle, N, McCarthy, H, Parry, H, Patten, PEM, Riches, JC, Hillmen, P & Schuh, AH 2022, 'Guideline for the treatment of chronic lymphocytic leukaemia', British Journal of Haematology, vol. 197, no. 5, pp. 544-557. https://doi.org/10.1111/bjh.18075
Parry, H, McIlroy, G, Moss, P, Damery, S, Tyson, G, Logan, N, Davis, C, Willett, B, Zuo, J, Ali, M, Kaur, M, Stephens, C, Brant, D, Otter, A, McSkeane, T, Rolfe, H, Faustini, S, Richter, A, Lee, S, Wandroo, F, Shafeek, S, Pratt, G, Paneesha, S & Moss, P 2022, 'Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia', Journal of Hematology and Oncology, vol. 15, no. 1, 3. https://doi.org/10.1186/s13045-021-01219-7
Tye, E, Jinks, E, Haigh, T, Kaul, B, Patel, P, Parry, H, Newby, M, Crispin, M, Kaur, N, Moss, P, Drennan, S, Taylor, G & Long, H 2022, 'Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4+ T cell recognition', Nature Immunology, vol. 23, pp. 1726–1734. https://doi.org/10.1038/s41590-022-01351-7
Shields, AM, Venkatachalam, S, Shafeek, S, Paneesha, S, Ford, M, Sheeran, T, Kelly, M, Qureshi, I, Salhan, B, Karim, F, De Silva, N, Stones, J, Lee, S, Khawaja, J, Kaudlay, PK, Whitmill, R, Kakepoto, GN, Parry, HM, Moss, P, Faustini, SE, Richter, AG, Drayson, MT & Basu, S 2022, 'SARS-CoV-2 vaccine responses following CD20-depletion treatment in patients with haematological and rheumatological disease: a West Midlands Research Consortium study', Clinical and Experimental Immunology, vol. 207, no. 1, pp. 3-10. https://doi.org/10.1093/cei/uxab018
CHAMPION steering committee members, Constantine, A, Dimopoulos, K, Jenkins, P, Tulloh, RMR, Condliffe, R, Jansen, K, Chung, NAY, Oliver, J, Parry, H, Fitzsimmons, S, Walker, N, Wort, SJ, Papaioannou, V, von Klemperer, K & Clift, P 2022, 'Use of Pulmonary Arterial Hypertension Therapies in Patients with a Fontan Circulation: Current Practice Across the United Kingdom.', Journal of the American Heart Association, vol. 11, no. 1, e023035. https://doi.org/10.1161/jaha.121.023035
Letter
Roberts, T, Uwenedi, G, Bruton, R, McIlroy, G, Damery, S, Sylla, P, Logan, N, Scott, S, Lau, M, Elzaidi, A, Plass, S, Mallick, S, Spencer, K, Stephens, C, Bentley, C, Pratt, G, Zuo, J, Paneesha, S, Willett, B, Moss, P & Parry, H 2024, 'Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemia', Blood Cancer Journal, vol. 14, no. 1, 22. https://doi.org/10.1038/s41408-023-00940-5
Farhat, M, Croft, W, Parry, HM, Verma, K, Kinsella, FAM, Xu, J, Bone, D, McSkeane, T, Paneesha, S, Pratt, G, Moss, P & Zuo, J 2024, 'PD-1 expression contributes to functional impairment of NK cells in patients with B-CLL', Leukemia, vol. 38, no. 8, pp. 1813-1817. https://doi.org/10.1038/s41375-024-02271-1
Parry, H, Moss, P, Uwenedi, G, Roberts, T, Sylla, P, Cook, J, Elzaidi, A, Lau, M, Drury, T, Bray, A, Mallick, S, Spencer, K, Bentley, C, Mcilroy, G, Scott, S, Logan, N, Zuo, J, Willett, B & Moss, P 2023, 'Robust generation of neutralising antibodies against Omicron variants following bivalent mRNA booster vaccine in elderly people aged >80 years', Journal of Infection. https://doi.org/10.1016/j.jinf.2023.08.014
Parry, H, Bruton, R, Roberts, T, Mcilroy, G, Damery, S, Sylla, P, Dowell, AC, Tut, G, Lancaster, T, Bone, D, Willett, B, Logan, N, Scott, S, Hulme, S, Jadir, A, Amin, U, Nicol, S, Stephens, C, Faustini, S, Al-taei, S, Richter, A, Blakeway, D, Verma, K, Margielewska-davies, S, Pearce, H, Pratt, G, Zuo, J, Paneesha, S & Moss, P 2022, 'COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia', Cancer Cell, vol. 40, no. 6, pp. 584-586. https://doi.org/10.1016/j.ccell.2022.05.001
View all publications in research portal